Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 M Supply Disruption — GlaxoSmithKline, LLC (Moderat
Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 M Supply Disruption — GlaxoSmithKline, LLC (Moderat is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 M; Manufacturer: Glaxo
| Drug name | Ventolin HFA (albuterol sulfate) Inhalation Aerosol, 90 mcg per actuation, 200 M |
|---|---|
| Manufacturer | GlaxoSmithKline, LLC |
| Recall/Disruption reason | Defective Delivery System: Elevated number of units with out of specification results for leak rate. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-0626-2017 |
| Initiation date | 20170322 |
| Quantity affected | 593,088 inhalers |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →